Brazil approves Pfizer vaccine for children as young as six months
Brazilian national health regulator Anvisa has approved the COVID-19 vaccine produced by Pfizer and BioNTech for children aged between six months and four years, the government body said in a statement Friday night.
- Country:
- Brazil
Brazilian national health regulator Anvisa has approved the COVID-19 vaccine produced by Pfizer and BioNTech for children aged between six months and four years, the government body said in a statement Friday night. The move broadens the availability of the vaccine, which is sold under the brand name Comirnaty for adults and is already available in Brazil for older age groups.
Brazil's vaccination rates are already among the world's highest, with almost 90% of the population having received at least one dose, according to the Our World in Data project, which collects official numbers from governments worldwide. On Friday, the South American country reported 97 deaths nationwide due to the coronavirus, far lower than the daily peak of 4,250 recorded in April 2021.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
Italy plans to invite South American, African countries to June G7 summit
Italy to invite African, South American leaders to G7 summit
Italy to invite African, South American leaders to G7 summit
Health News Roundup: GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology; Gilead posts quarterly loss, revenue rises 5% and more
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology